Recent advances in the understanding of sepsis-induced alterations in the neuroendocrine system

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 13, Issue 4, 2013, Pages 335-347

  Wahab, Fazal ^a,b   Atika, Bibi ^b   Oliveira Pelegrin, Gabriela Ravanelli ^a   Rocha, Maria José Alves ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b KHYBER MEDICAL UNIVERSITY   (Pakistan)

Author keywords

Cytokines; Hormonal therapy; Hypothalamus; Immune system; Neuroendocrine system; Neuroendocrinopathy; Pituitary; Sepsis

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DIAZEPAM; FOLLITROPIN; GLUCOCORTICOID; GONADORELIN; GROWTH HORMONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDOMETACIN; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIOTHYRONINE; LUTEINIZING HORMONE; NITRIC OXIDE; NORADRENALIN; OPIATE; OXYTOCIN; PROLACTIN; PROLACTIN RELEASING FACTOR; PROLACTOSTATIN; PROTIRELIN; SOMATOMEDIN C; THYROTROPIN; THYROXINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNINDEXED DRUG; VASOPRESSIN;

ANATOMICAL VARIATION; APOPTOSIS; CYTOKINE RELEASE; GENE EXPRESSION; GROWTH REGULATION; HUMAN; INFLAMMATION; LACTOTROPIC CELL; NEUROENDOCRINE DISEASE; NEUROENDOCRINE SYSTEM; NEUROSECRETORY CELL; NONHUMAN; REPRODUCTION; REVIEW; SEPSIS; STRESS; THYROID FUNCTION; ANIMAL; COMPREHENSION; IMMUNOLOGY; METABOLISM; NEUROSECRETION; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; COMPREHENSION; HUMANS; NEUROSECRETORY SYSTEMS; SEPSIS; SIGNAL TRANSDUCTION;

EID: 84895444061     PISSN: 18715303     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/1871530313666131211120723     Document Type: Review

References (133)

1. Martin, G.S. (2012) Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev. Anti. Infect. Ther., 10, 701-706.
2. Calandra, T. and Cohen, J. (2005) The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit. Care. Med., 33, 1538-1548.
3. Vincent, J.L.; Opal, S.M.; Marshall, J.C. and Tracey, K.J. (2013) Sepsis definitions: time for change. Lancet, 381, 774-775.
4. Oberholzer, A.; Oberholzer, C. and Moldawer, L.L. (2001) Sepsis syndromes: understanding the role of innate and acquired immunity. Shock Augusta Ga., 16, 83-96.
5. Castellheim, A.; Brekke, O-L.; Espevik, T.; Harboe, M. and Mollnes, T.E. (2009) Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand. J. Immunol., 69, 479-491.
6. Delaloye, J. and Calandra, T. (2013) Host innate immune responses to microbial pathogens. Curr. Vasc. Pharmacol., 11, 123-132.
7. Van der Poll, T.; van Zoelen, M.A.D. and Wiersinga, W.J. (2011) Regulation of pro-and anti-inflammatory host responses. Contrib. Microbiol., 17, 125-136.
8. Shubin, N.J.; Monaghan, S.F. and Ayala, A. (2011) Antiinflammatory mechanisms of sepsis. Contrib. Microbiol., 17, 108-24.
9. Kunwar, S. In: Neuroendocrinology; Mitchel, S.B.; Michael, D.P., Eds.; Textb. Neuro-Oncol.; W.B. Saunders: Philadelphia, 2005; Chap. 6, p. 45-52.
10. Ben-Shlomo, A. and Melmed, S. In: Hypothalamic Regulation of Anterior Pituitary Function. Shlomo, M., Ed.; Pituit. Third Ed., Academic Press San Diego: 2011; chap. 2, p. 21-45.
11. Polito, A.; Sonneville, R.; Guidoux, C.; Barrett, L.; Viltart, O.; Mattot, V.; Siami, S.; Lorin de la Grandmaison, G.; Chrétien, F.; Singer, M.; Gray, F.; Annane, D.; Brouland, J.P. and Sharshar, T. (2011) Changes in CRH and ACTH synthesis during experimental and human septic shock. Plos One, 6, e25905.
12. Cui, N.; Liu, D.; Wang, H.; Zeng, Z.; Long, Y.; Chai W, Liu, H.Z. and Wang, X.T. (2007) [Early changes in function of hypothalamic-pituitary-target gland axis in patients with severe sepsis and septic shock]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue Chin. Crit. Care Med Zhongguo Weizhongbing Jijiuyixue, 19, 332-335.
13. Lawler, D.A. (1994) Hormonal response in sepsis. Crit. Care Nurs. Clin. North Am., 6, 265-274.
14. Langouche, L. and Van den Berghe, G. (2006) The dynamic neuroendocrine response to critical illness. Endocrinol. Metab. Clin. North Am., 35, 777-791.
15. Oliveira-Pelegrin, G.R.; Ravanelli, M.I.B.; Branco, L.G.S. and Rocha, M.J.A. (2009) Thermoregulation and vasopressin secretion during polymicrobial sepsis. Neuroimmunomodulation, 16, 45-53.
16. Carnio, E.C.; Moreto, V.; Giusti-Paiva, A. and Antunes-Rodrigues, J. (2006) Neuro-immune-endocrine mechanisms during septic shock: role for nitric oxide in vasopressin and oxytocin release. Endocr. Metab. Immune Disord. Drug Targets, 6, 137-142.
17. Sonneville, R.; Guidoux, C.; Barrett, L.; Viltart, O.; Mattot, V.; Polito, A.; Siami, S.; de la Grandmaison, G.L.; Blanchard, A.; Singer, M.; Annane, D.; Gray, F.; Brouland, J.P. and Sharshar, T. (2010) Vasopressin synthesis by the magnocellular neurons is different in the supraoptic nucleus and in the paraventricular nucleus in human and experimental septic shock. Brain Pathol. Zurich Switz., 20, 613-622.
18. Sharshar, T.; Blanchard, A.; Paillard, M.; Raphael, J.C.; Gajdos, P. and Annane, D. (2003) Circulating vasopressin levels in septic shock. Crit. Care Med., 31, 1752-1758.
19. Sharshar, T. and Annane, D. (2008) Endocrine effects of vasopressin in critically ill patients. Best Pract. Res. Clin. Anaesthesiol., 22, 265-273.
20. Van den Berghe, G. (2003) Endocrine evaluation of patients with critical illness. Endocrinol. Metab. Clin. North Am., 32, 385-410.
21. Berghe, G.V.; de den Zegher, F. and Bouillon, R. (1998) Acute and Prolonged Critical Illness as Different Neuroendocrine Paradigms. J. Clin. Endocrinol. Metab., 83, 1827-1834.
22. Russell, J.A. (2011) Bench-to-bedside review: Vasopressin in the management of septic shock. Crit. Care, 15, 226.
23. Warren, R.S.; Donner, D.B.; Starnes, Jr. H.F. and Brennan, M.F. (1987) Modulation of endogenous hormone action by recombinant human tumor necrosis factor. Proc. Natl. Acad. Sci. USA, 84, 8619-8622.
24. Beisel, W.R. (1995) Herman Award lecture, 1995: Infectioninduced malnutrition-from cholera to cytokines. Am. J. Clin. Nutr., 62, 813-819.
25. Bistrian, B.R.; Schwartz, J. and Istfan, N.W. (1992) Cytokines, Muscle Proteolysis, and the Catabolic Response to Infection and Inflammation. Proc. Soc. Exp. Biol. Med. New York N., 200, 220-223.
26. Arzt, E.; Pereda, M.P.; Castro, C.P.; Pagotto, U; Renner, U. and Stalla, G.K. (1999) Pathophysiological Role of the Cytokine Network in the Anterior Pituitary Gland. Front. Neuroendocrinol., 20, 71-95.
27. Plant, T.M. (2008) Hypothalamic control of the pituitary-gonadal axis in higher primates: key advances over the last two decades. J. Neuroendocrinol., 20, 719-726.
28. Clarke, I.J. (2011) Control of GnRH secretion: one step back. Front. Neuroendocrinol., 32, 367-375.
29. Wahab, F.; Atika, B. and Shahab, M. (2013) Kisspeptin as a link between metabolism and reproduction: Evidences from rodent and primate studies. Metabolism, 62, 898-910.
30. Wahab, F.; Quinton, R. and Seminara, S.B. (2011) The kisspeptin signaling pathway and its role in human isolated GnRH deficiency. Mol. Cell Endocrinol., 346, 29-36.
31. Tsutsui, K.; Bentley, G.E.; Bedecarrats, G.; Osugi, T.; Ubuka, T. and Kriegsfeld, L.J. (2010) Gonadotropin-inhibitory hormone (GnIH) and its control of central and peripheral reproductive function. Front. Neuroendocrinol., 31, 284-295.
32. Tomaszewska-Zaremba, D. and Herman, A. (2009) The role of immunological system in the regulation of gonadoliberin and gonadotropin secretion. Reprod. Biol., 9, 11-23.
33. Igaz, P.; Salvi, R.; Rey, J.P.; Glauser, M.; Pralong, F.P. and Gaillard, R.C. (2006) Effects of cytokines on gonadotropinreleasing hormone (GnRH) gene expression in primary hypothalamic neurons and in GnRH neurons immortalized conditionally. Endocrinology, 147, 1037-1043.
34. Kalra, P.S.; Edwards, T.G.; Xu, B.; Jain, M. and Kalra, S.P. (1998) The anti-gonadotropic effects of cytokines: the role of neuropeptides. Domest. Anim. Endocrinol., 15, 321-332.
35. Rivier, C. and Vale, W. (1990) Cytokines act within the brain to inhibit luteinizing hormone secretion and ovulation in the rat. Endocrinology, 127, 849-856.
36. Rivest, S.; Lee, S.; Attardi, B. and Rivier, C. (1993) The chronic intracerebroventricular infusion of interleukin-1β alters the activity of the hypothalamic-pituitary-gonadal axis of cycling rats. I. Effect on LHRH and gonadotropin biosynthesis and secretion. Endocrinology, 133, 2424-2430.
37. Watanobe, H. and Hayakawa Y. (2003) Hypothalamic Interleukin-1β and Tumor Necrosis Factor-β, But Not Interleukin-6, Mediate the Endotoxin-Induced Suppression of the Reproductive Axis in Rats. Endocrinology, 144, 4868-4875.
38. Rivest, S. and Rivier, C. (1993) Centrally injected interleukin-1 beta inhibits the hypothalamic LHRH secretion and circulating LH levels via prostaglandins in rats. J. Neuroendocrinol., 5, 445-50.
39. Kang, S.S.; Kim, S.R.; Leonhardt, S.; Jarry, H.; Wuttke, W. and Kim, K. (2000) Effect of interleukin-1beta on gonadotropinreleasing hormone (GnRH) and GnRH receptor gene expression in castrated male rats. J. Neuroendocrinol., 12, 421-429.
40. Nappi, R.E. and Rivest, S. (1997) Effect of immune and metabolic challenges on the luteinizing hormone-releasing hormone neuronal system in cycling female rats: an evaluation at the transcriptional level. Endocrinology, 138, 1374-1384.
41. Pinilla, L.; Aguilar, E.; Dieguez, C.; Millar, R.P. and Tena-Sempere, M. (2012) Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol. Rev., 92, 1235-1316.
42. Castellano, J.M.; Bentsen, A.H.; Romero, M.; Pineda, R.; Ruiz-Pino, F.; Garcia-Galiano, D.; Sánchez-Garrido, M.A.; Pinilla, L.; Mikkelsen, J.D. and Tena-Sempere M. (2010) Acute inflammation reduces kisspeptin immunoreactivity at the arcuate nucleus and decreases responsiveness to kisspeptin independently of its anorectic effects. Am. J. Physiol. Endocrinol. Metab., 299, E54-61.
43. Iwasa T.; Matsuzaki T.; Murakami M.; Shimizu F.; Kuwahara A.; Yasui T. and Irahara, M. (2008) Decreased expression of kisspeptin mediates acute immune/inflammatory stress-induced suppression of gonadotropin secretion in female rat. J. Endocrinol. Invest., 31, 656-659.
44. Melmed, S. (2010) The Pituitary: Third Edition. Academic Press.
45. Ross, R.; Miell, J.; Freeman, E.; Jones, J.; Matthews, D.; Preece, M. and Buchanan, C. (1991) Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I. Clin. Endocrinol. (Oxf), 35, 47-54.
46. Dahn, M.S.; Lange, P. and Jacobs, L.A. (1988) Insulinlike growth factor 1 production is inhibited in human sepsis. Arch. Surg., 123, 1409-1414.
47. Clark, M.A.; Hentzen, B.T.H.; Plank, L.D. and Hill, G.L. (1996) Sequential changes in insulin-like growth factor 1, plasma proteins, and total body protein in severe sepsis and multiple injury. J. Parenter Enter Nutr., 20, 363-370.
48. Heemskerk, V.H.; Daemen, M.A.R. and Buurman, W.A. (1999) Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation. Cytokine Growth Factor Rev., 10, 5-14.
49. Yumet, G.; Shumate, M.L.; Bryant, P.; Lin, C.M.; Lang, C.H. and Cooney, R.N. (2002) Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis. Am. J. Physiol-Endocrinol. Metab., 283, E472-E481.
50. Van den Berghe, G.; de Zegher, F.; Veldhuis, J.D.; Wouters, P.; Awouters, M.; Verbruggen, W.; Schetz, M.; Verwaest, C.; Lauwers, P.; Bouillon, R. and Bowers, C.Y. (1997) The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. J. Clin. Endocrinol. Metab., 82, 590-599.
51. Brabant, G.; Prank, K.; Hoang-Vu, C.; Hesch, R.D. and von zur Mühlen, A. (1991) Hypothalamic regulation of pulsatile thyrotopin secretion. J. Clin. Endocrinol. Metab., 72, 145-150.
52. Adler, S.M. and Wartofsky, L. (2007) The Nonthyroidal Illness Syndrome. Endocrinol. Metab. Clin. North Am., 36, 657-672.
53. Dennhardt, R.; Gramm, H.J.; Meinhold, K. and Voigt. K. (1989) Patterns of endocrine secretion during sepsis. Prog. Clin. Biol. Res., 308, 751-756.
54. De Jongh, F.E.; Jöbsis, A.C. and Elte, J.W. (2001) Thyroid morphology in lethal non-thyroidal illness: a post-mortem study. Eur. J. Endocrinol., 144, 221-226.
55. Maxime, V.; Siami, S. and Annane, D. (2007) Metabolism modulators in sepsis: the abnormal pituitary response. Crit. Care Med., 35, S596-601.
56. Van den Berghe, G.; de Zegher, F.; Baxter, R.C.; Veldhuis, J.D.; Wouters, P.; Schetz, M.; Verwaest, C.; Van der Vorst, E.; Lauwers, P.; Bouillon, R. and Bowers, C.Y. (1998) Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropinreleasing hormone and its combination with growth hormone secretagogues. J. Clin. Endocrinol. Metab., 83, 309-319.
57. Fliers, E.; Guldenaar, S.E.; Wiersinga, W.M. and Swaab, D.F. (1997) Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J. Clin. Endocrinol. Metab., 82, 4032-4036.
58. Arem, R.; Wiener, G.J.; Kaplan, S.G.; Kim, H.S.; Reichlin, S. and Kaplan, M.M. (1993) Reduced tissue thyroid hormone levels in fatal illness. Metabolism, 42, 1102-1108.
59. Shelly, S.; Boaz, M. and Orbach, H. (2012) Prolactin and autoimmunity. Autoimmun Rev., 11, A465-A470.
60. Płociński, P.; Dzitko, K. and Długońska, H. (2007) Prolactin as a modulator of antiparasitic immunity. Wiadomości Parazytol., 53, 263-270.
61. Oberbeck, R.; Schmitz, D.; Wilsenack, K.; Schüler, M.; Biskup, C.; Schedlowski, M.; Nast-Kolb, D. and Exton, M.S. (2003) Prolactin modulates survival and cellular immune functions in septic mice. J. Surg. Res., 113, 248-256.
62. Papadimitriou, A. and Priftis, K.N. (2009) Regulation of the hypothalamic-pituitary-adrenal axis. Neuroimmunomodulation, 16, 265-271.
63. Sweep, F.; Rijnkels, C. and Hermus, A. (1991) Activation of the hypothalamus-pituitary-adrenal axis by cytokines. Acta. Endocrinol. (Copenh), 125 Suppl 1, 84-91.
64. Van der Meer, M.J.; Sweep, C.G.; Rijnkels, C.E.; Pesman, G.J.; Tilders, F.J.; Kloppenborg, P.W. and Hermus, R. (1996) Acute stimulation of the hypothalamic-pituitary-adrenal axis by IL-1 beta, TNF alpha and IL-6, a dose response study. J. Endocrinol. Invest., 19, 175-182.
65. Van der Meer, M.J.; Sweep, C.G.; Pesman, G.J.; Tilders, F.J. and Hermus, A.R. (1996) Chronic stimulation of the hypothalamuspituitary-adrenal axis in rats by interleukin 1beta: central and peripheral mechanisms. Cytokine, 8, 910-919.
66. Schroeder, S.; Wichers, M.; Klingmüller, D.; Höfer, M.; Lehmann, L.E.; von Spiegel, T.; Hering, R.; Putensen, C.; Hoeft, A. and Stüber, F. (2001) The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropinreleasing hormone. Crit. Care Med., 29, 310-316.
67. Carlson, D.E.; Chiu, W.C. and Scalea, T.M. (2006) Cecal ligation and puncture in rats interrupts the circadian rhythms of corticosterone and adrenocortical responsiveness to adrenocorticotrophic hormone. Crit. Care Med., 34, 1178-1184.
68. Leng, G.; Ludwig, M. and Douglas, A.J. Chapter 6-Neural Control of the Posterior Pituitary Gland (Neurohypophysis). In: George Fink, Donald W. Pfaff and Jon LevineA2-George Fink DWP, Jon Levine, editors. Handb. Neuroendocr., San Diego: Academic Press, 2012, Chap. 6, p. 139-155.
69. Caldwell, H.K. and Li, W.S.Y. In: Oxytocin and Vasopressin: Genetics and Behavioral Implications. Lajtha, A., Lim, R., Eds.; Handb. Neurochem. Mol. Neurobiol., Springer US, 2006; p. 573-607.
70. Robertson, G.L. (2001) Antidiuretic hormone. Normal and disordered function. Endocrinol. Metab. Clin. North Am., 30, 671-694.
71. Pancoto, J.A.T.; Corrêa, P.B.F.; Oliveira-Pelegrin, G.R. and Rocha, M.J.A. (2008) Autonomic dysfunction in experimental sepsis induced by cecal ligation and puncture. Auton. Neurosci., 138, 57-63.
72. Sharshar, T.; Carlier, R.; Blanchard, A.; Feydy, A.; Gray, F.; Paillard, M.; Raphael, J.C.; Gajdos, P. and Annane, D. (2002) Depletion of neurohypophyseal content of vasopressin in septic shock*. Crit. Care Med., 30, 497-500.
73. Landry, D.W.; Levin, H.R.; Gallant, E.M.; Ashton, R.C.; Seo, S.; D'Alessandro, D.; Oz, M.C. and Oliver, J.A. (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation, 95, 1122-1125.
74. Epstein, F.H.; Landry, D.W. and Oliver, J.A. (2001) The pathogenesis of vasodilatory shock. N. Engl. J. Med., 345, 588-595.
75. De Carvalho Borges, B.; Carnio, E.C.; Elias, L.L.K.; Antunes-Rodrigues, J.; Branco, L.G.S. and Rocha, M.J.A. (2006) Lesion of the anteroventral third ventricle (AV3V) reduces hypothalamic activation and hypophyseal hormone secretion induced by lipopolysaccharide in rats. Brain Res., 1115, 83-91.
76. Oliveira-Pelegrin, G.R.; Basso, P.J.; Soares, A.S.; Martinez, M.R.; Riester, K.D. and Rocha, M.J.A. (2013) Cleaved caspase-3 expression in hypothalamic magnocellular neurons may affect vasopressin secretion during experimental polymicrobial sepsis. J. Neuroimmunol., 258, 10-16.
77. Borges, B.C. and Rocha, M.J.A. (2006) Participation of the subfornical nucleus in hypothalamic-neurohypophyseal axis activation during the early phase of endotoxic shock. Neurosci. Lett., 404, 227-231.
78. Giusti-Paiva, A.; Elias, L.L.K. and Antunes-Rodrigues, J. (2005) Inhibitory effect of gaseous neuromodulators in vasopressin and oxytocin release induced by endotoxin in rats. Neurosci. Lett., 381, 320-324.
79. Oliveira-Pelegrin, G.R.; Saia, R.S.; Cárnio, E.C. and Rocha, M.J.A. (2013) Oxytocin affects nitric oxide and cytokine production by sepsis-sensitized macrophages. Neuroimmunomodulation, 20, 65-71.
80. Athayde, L.A.; Oliveira-Pelegrin, G.R.; Nomizo, A.; Faccioli, L.H. and Rocha, M.J.A. (2009) Blocking central leukotrienes synthesis affects vasopressin release during sepsis. Neuroscience, 160, 829-836.
81. Martins, T.F.; Sorgi, C.A.; Faccioli, L.H. and Rocha, M.J.A. (2011) Leukotriene synthesis inhibitor decreases vasopressin release in the early phase of sepsis. J. Neuroimmunol., 238, 52-57.
82. Wahab, F.; Aziz, F.; Irfan, S.; Zaman, W.U. and Shahab, M. (2008) Short-term fasting attenuates the response of the HPG axis to kisspeptin challenge in the adult male rhesus monkey (Macaca mulatta). Life Sci., 83, 633-637.
83. Rohleder, N. and Kirschbaum, C. (2007) Effects of nutrition on neuro-endocrine stress responses. Curr. Opin. Clin. Nutr. Metab. Care, 10, 504-510.
84. Wahab, F.; Ullah, F.; Chan, Y.M.; Seminara, S.B. and Shahab, M. (2011) Decrease in hypothalamic Kiss1 and Kiss1r expression, a potential mechanism for fasting-induced suppression of the HPG axis in the adult male rhesus monkey (Macaca mulatta). Horm. Metab. Res., 43, 81-85.
85. Srebnik, H.H. and Nelson, M.M. (1962) Anterior Pituitary Function in Male Rats Deprived of Dietary Protein. Endocrinology, 70, 723-730.
86. Richmand, D.A.; Molitch, M.E. and O'Donnell, T.F. (1980) Altered thyroid hormone levels in bacterial sepsis: The role of nutritional adequacy. Metabolism, 29, 936-942.
87. Jeejeebhoy, K.N. (2012) Malnutrition, fatigue, frailty, vulnerability, sarcopenia and cachexia: overlap of clinical features. Curr. Opin. Clin. Nutr. Metab. Care, 15, 213-219.
88. Sharshar, T.; Hopkinson, N.S.; Orlikowski, D. and Annane, D. (2004) Science review: The brain in sepsis-culprit and victim. Crit. Care, 9, 37.
89. McCann, S.M.; Kimura, M.; Yu, W.H.; Mastronardi, C.A.; Rettori, V. and Karanth, S. (2001) Cytokines and pituitary hormone secretion. Vitam. Horm., 63, 29-62.
90. Lyson, K. and McCann, S.M. (1991) The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology, 54, 262-266.
91. McCann, S.M.; Kimura, M.; Karanth, S.; Yu, W.H.; Mastronardi, C.A. and Rettori, V. (2000) The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection. Ann. N. Y. Acad. Sci., 917, 4-18.
92. Jones, T.H. and Kennedy, R.L. (1993) Cytokines and hypothalamic-pituitary function. Cytokine, 5, 531-538.
93. Gabellec, M.M.; Griffais, R.; Fillion, G. and Haour, F. (1995) Expression of interleukin 1α, interleukin 1β and interleukin 1 receptor antagonist mRNA in mouse brain: regulation by bacterial lipopolysaccharide (LPS) treatment. Mol. Brain. Res., 31, 122-130.
94. Pan, W.; Xiang, S.; Tu, H. and Kastin, A.J. In: Cytokines Interact with the Blood-Brain Barrier. Dermietzel, R.; Spray, D. C; Nedergaard, I., Eds., Blood-Brain Barriers, Wiley-VCH Verlag GmbH & Co: KGaA, 2007; p. 247-264.
95. Koenig, J.I.; Snow, K.; Clark, B.D.; Toni, R.; Cannon, J.G.; Shaw, A.R.; Dinarello, C.A.; Reichlin, S.; Lee, S.L. and Lechan, R.M. (1990) Intrinsic pituitary interleukin-1β is induced by bacterial lipopolysaccharide. Endocrinology, 126, 3053-3058.
96. Moretto, M.; López, F.J. and Negro-Vilar, A. (1993) Nitric oxide regulates luteinizing hormone-releasing hormone secretion. Endocrinology, 133, 2399-2402.
97. Prevot, V.; Rialas, C.M.; Croix, D.; Salzet, M.; Dupouy, J.P.; Poulain, P.; Beauvillain, J.C. and Stefano, G.B. (1998) Morphine and anandamide coupling to nitric oxide stimulates GnRH and CRF release from rat median eminence: neurovascular regulation. Brain Res., 790, 236-244.
98. Nelson, R.J.; Kriegsfeld, L.J.; Dawson, V.L. and Dawson, T.M. (1997) Effects of Nitric Oxide on Neuroendocrine Function and Behavior. Front. Neuroendocrinol., 18, 463-491.
99. Corrêa, P.B.F.; Pancoto, J.A.T.; de Oliveira-Pelegrin, G.R.; Cárnio, E.C. and Rocha, M.J.A. (2007) Participation of iNOS-derived NO in hypothalamic activation and vasopressin release during polymicrobial sepsis. J. Neuroimmunol., 183, 17-25.
100. Wong, M.L.; Rettori, V.; AL-Shekhlee, A.; Bongiorno, P.B.; Canteros, G.; McCann, S.M.; Gold, P.W. and Licinio, J. (1996) Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat. Med., 2, 581-584.
101. Feihl, F.; Waeber, B. and Liaudet, L. (2001) Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol. Ther., 91, 179-213.
102. Oliveira-Pelegrin, G.R.; Aguila, F.A.; Basso, P.J. and Rocha, M.J.A. (2010) Role of central NO-cGMP pathway in vasopressin and oxytocin gene expression during sepsis. Peptides, 31, 1847-1852.
103. Palmer, R.M.J. and Moncada, S. (1989) A novel citrullineforming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem. Biophys. Res. Commun., 158, 348-352.
104. Wong, J.M. and Billiar, T.R. In: Regulation and Function of Inducible Nitric Oxide Synthase during Sepsis and Acute Inflammation. Louis, I. and Ferid, M., Eds.; Adv. Pharmacol., Academic Press, 1995; Vol. 34, p. 155-170.
105. Lowenstein, C.J.; Dinerman, J.L. and Snyder, S.H. (1994) Nitric Oxide: A Physiologic Messenger. Ann. Intern. Med., 120, 227-237.
106. Feihl, F.; Waeber, B. and Liaudet, L. (2001) Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol. Ther., 91, 179-213.
107. Oliveira-Pelegrin, G.R.; de Azevedo, S.V.; Yao, S.T.; Murphy, D. and Rocha, M.J.A. (2010) Central NOS inhibition differentially affects vasopressin gene expression in hypothalamic nuclei in septic rats. J. Neuroimmunol., 227, 80-86.
108. Sharshar, T.; Gray, F.; de la Grandmaison, G.L.; Hopklnson, N.S.; Ross, E.; Dorandeu, A.; Orlikowski, D.; Raphael, J.C.; Gajdos, P. and Annane, D. (2003) Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. The Lancet, 362, 1799-1805.
109. Mander, P.; Borutaite, V.; Moncada, S. and Brown, G.C. (2005) Nitric oxide from inflammatory-activated glia synergizes with hypoxia to induce neuronal death. J. Neurosci. Res., 79, 208-215.
110. Mander, P. and Brown, G.C. (2004) Nitric oxide, hypoxia and brain inflammation. Biochem. Soc. Trans., 32, 1068-1069.
111. Erusalimsky, J.D. and Moncada, S. (2007) Nitric oxide and mitochondrial signaling from physiology to pathophysiology. Arterioscler. Thromb. Vasc. Biol., 27, 2524-31.
112. Brown, G.C. and Cooper, C.E. (1994) Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. Febs. Lett., 356, 295-298.
113. Cooper, C.E. and Brown, G.C. (2008) The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance. J. Bioenerg. Biomembr., 40, 533-539.
114. Moncada, S. and Erusalimsky, J.D. (2002) Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat. Rev. Mol. Cell Biol., 3, 214-220.
115. Ghafourifar, P. and Cadenas, E. (2005) Mitochondrial nitric oxide synthase. Trends Pharmacol. Sci., 26, 190-195.
116. Guix, F.X.; Uribesalgo, I.; Coma, M. and Munoz, F.J. (2005) The physiology and pathophysiology of nitric oxide in the brain. Prog. Neurobiol., 76, 126-152.
117. Sharp, F.R. and Bernaudin, M. (2004) HIF1 and oxygen sensing in the brain. Nat. Rev. Neurosci., 5, 437-448.
118. Bruick, R.K. (2000) Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl. Acad. Sci., 97, 9082-9087.
119. Lyson, K. and McCann, S.M. (1991) The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology, 54, 262-266.
120. Spangelo, B.L.; Isakson, P.C. and MacLeod, R.M. (1990) Production of interleukin-6 by anterior pituitary cells is stimulated by increased intracellular adenosine 3',5'-monophosphate and vasoactive intestinal peptide. Endocrinology, 127, 403-409.
121. Gatti, S. and Bartfai, T. (1992) Induction of tumor necrosis factor-α mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res., 624, 291-294.
122. Prigent, H.; Maxime, V. and Annane, D. (2004) Science review: Mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids. Crit. Care, 8, 243-252.
123. Russell, J.A.; Fjell, C.; Hsu, J.L.; Lee, T.; Boyd, J.; Thair, S.; Singer, J.; Patterson, A.J. and Walley, K.R. (2013) Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock. Am. J. Respir. Crit. Care Med., 188, 356-364.
124. Choong, K. (2012). Hormonal Therapies in Severe Sepsis, Severe Sepsis and Septic Shock-Understanding a Serious Killer, Dr Ricardo Fernandez (Ed.), ISBN: 978-953-307-950-9, InTech, DOI: 10.5772/29577. Available from: http://www.intechopen.com/ books/severe-sepsis-and-septic-shock-understanding-a-seriouskiller/ hormonal-therapies-in-severe-sepsis.
125. Felmet, K.; Choong, K. and Kissoon, N. (2009) Hormonal therapies in septic shock. Pediatr. Infect. Dis. J., 4, 119-126.
126. Yildiz, O.; Tanriverdi, F.; Simsek, S.; Aygen, B. and Kelestimur, F. (2011) The effects of moderate-dose steroid therapy in sepsis: A placebo-controlled, randomized study. J Res Med Sci., 16, 1410-1421.
127. Schulte, W.; Bernhagen, J. and and Bucala, R. (2013) Cytokines in Sepsis: potent immunoregulators and potential therapeutic targets an updated view. Mediators Inflamm., 2013, 165974.
128. Fisher, J.C. Jr.; Opal, S.M.; Dhainaut, F.J.; Stephens, S.; Zimmerman, J.L.; Nightingale, P.; Harris, S.J.; Schein, R.M.; Panacek, E.A. and Vincent, J.L. (1993) Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit. Care Med., 21, 318-327.
129. Fisher, J. C. Jr.; Agosti, J.M.; Opal, J.M.; Lowry, S.F.; Balk, R.A.; Sadoff, J.C.; Abraham, E.; Schein, R.M. and Benjamin, E. (1996) Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N. Engl. J. Med., 334, 1697-1702.
130. Opal, S. M., Fisher, C.J. Jr.; Dhainaut, J.A.; Vincent, J.L.; Brase, R.; Lowry, S.F.; Sadoff, J.C.; Slotman, G.J.; Levy, H.; Balk, R.A.; Shelly, M.P.; Pribble, J.P.; LaBrecque, J.F.; Lookabaugh, J.; Donovan, H.; Dubin, H.; Baughman, R.; Norman, J.; DeMaria, E.; Matzel, K.; Abraham, E. and Seneff, M. (1997) Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. Crit. Care Med., 25, 1115-1124.
131. Vanlaere, I. and Libert, C. (2009) Matrix Metalloproteinases as Drug Targets in Infections Caused by Gram-Negative Bacteria and in Septic Shock. Clin. Microbiol. Rev., 22, 224-239.
132. Wahab, F.; Tazinafo, L.F. and Rocha, M.J.A. (2013) Effect Of IL-1 Receptor Antagonist On Nitric Oxide Concentration In The Cerebrospinal Fluid During Experimental Polymicrobial Sepsis. Annual Meeting of Brazilian Physiological Society (SBFis 2013), Ribeirao Preto, Brazil.
133. Wahab, F.; Tazinafo, L.F.; Batalhão, M.F.; Carnio, E.C. and Rocha, M.J.A. (2013) Effect of IL-1 Receptor Antagonist on the Cerebrospinal Fluid Nitric Oxide Concentrations during Experimental Polymicrobial Sepsis in rats. Crit. Care, 17, P93.